Rondo Therapeutics

📍 Hayward, United States🗓 Founded 2021👥 22 employees💰 Last funded Feb 2024
Biotechnology🌐 rondotx.com
Website LinkedIn
At Rondo Therapeutics we believe that our success as a company starts with building a culture based on teamwork, trust, career growth, and a sense of fun. We develop innovative bispecific antibody therapies, specifically targeting unmet needs in solid tumors. Our bispecific antibodies are designed with broad therapeutic windows, sparing healthy tissue while eradicating tumors. If you are a fearless scientist driven to make new discoveries and you value collaboration, respect, and working in a team environment, then we want to hear from you! Join us in our mission to create novel molecules that bring new hope to cancer patients while advancing your career in a merit-based culture.
3
Total investors
2
Early stage
1
Mid stage
0
Late stage
2021
Founded

Investors

3 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
3
Investor activity2020–2024 · investors recorded per year
202012022120241
Recent (last 2y)Earlier
Frequently asked questions
Who invested in Rondo Therapeutics?
Rondo Therapeutics has 3 investors on record on gritt.io, including 2 early-stage backers, 1 mid-stage.
When did Rondo Therapeutics last raise funding?
The most recent investment in Rondo Therapeutics recorded on gritt.io was in February 2024.
When was Rondo Therapeutics founded?
Rondo Therapeutics was founded in 2021.
What industry is Rondo Therapeutics in?
Rondo Therapeutics operates in Biotechnology. Find similar Biotechnology investors on gritt.io.
Where is Rondo Therapeutics based?
Rondo Therapeutics is headquartered in Hayward, United States.